Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Recent Study Co-Authored by Veranex to be Presented at ISPOR 2024

Recent Study Co-Authored by Veranex to be Presented at ISPOR 2024

225,000 vitrectomy surgeries are performed annually in the U.S. A time-driven cost analysis conducted at a US academic hospital found the average true cost of routine vitrectomies (including macular hole (MH) surgeries) is $7,169.79 per patient, $2,000 above CMS’s 2019 reimbursed rate. This analysis aims to quantify the potential cost impact of improved MH closure rates using a 3D-HUD system at a US academic hospital.

4 min read

Giving Back

Nicolas Borenstein, DVM, Ph.D. Co-President, Preclinical Services “We are not a veterinary clinic and our primary mission is...

Read More

Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom

By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after...

Read More

Veranex Supports Retrospective Claims Analysis of Physical Therapy Utilization Among Women With Stress or Mixed Urinary Incontinence

Manasi Datar, Li-Chen Pan, and Thomas Goss, members of the Veranex Commercial Strategy and Market Access team, supported the retrospective...

Read More